Quadrivalent Influenza VLP Vaccine Dose Ranging Study in Young Adults

NCT02307851 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

400

Enrollment

INDUSTRY

Sponsor class

Conditions

Influenza

Interventions

BIOLOGICAL: Quadrivalent VLP Vaccine
BIOLOGICAL: Comparator TIV

Sponsor

Novavax

Collaborators

[object Object]